Literature DB >> 1580219

[Visual field change and risk factors for progression of visual field damage in low tension glaucoma].

H Shirai1, T Sakuma, S Sogano, Y Kitazawa.   

Abstract

The authors carried out a prospective study in an attempt to determine the possible effect of intraocular pressure (IOP) and some clinical factors on the clinical course of low tension glaucoma (LTG). During the study period all the patients were followed without any antiglaucoma medication. The enrollment criteria for the study were reproducible, mild to moderate field loss as defined as a mean defect (MD) of greater than 2 dB and less than 10 dB or corrected loss variance (CLV) of greater than 7 dB revealed by the Octopus 201, G1 program. Forty-two consecutive patients (56 eyes) who fulfilled this criteria were enrolled. Baseline and follow-up examinations included applanation tonometry, perimetry with G1 program, blood pressure and pulse rate. When the MD increased by 4 dB or more on two consecutive perimetry examinations, the field defect was judged as "progressed". During the follow-up period (6-51 months, 25.1 +/- 12.5 months), the field defect progressed in 14 eyes of 12 patients. The life-table analysis (Kaplan-Meier) revealed that the rate of nonprogression of visual field defects was 55.5% at 48 months. The rate of nonprogression was significantly lower in 16 eyes with a mean IOP equal to or higher than 15 mmHg as opposed to 40 eyes with that lower than 15 mmHg (34.3% and 67.2% respectively, p less than 0.05). The results seem to indicate that IOP is likely to be responsible for the aggravation of visual fields in LTG. Canonical discriminant analysis revealed that the discriminant function containing four variables gives the best separation between the "progressed" and "nonprogressed" group (discriminant efficacy: 83.9%).

Entities:  

Mesh:

Year:  1992        PMID: 1580219

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  2 in total

1.  Color Doppler imaging and pattern visual evoked potential in normal tension glaucoma and hypertension glaucoma.

Authors:  Yisheng Zhong; Yingjun Min; Ying Jiang; Yu Cheng; Jiao Qin; Xi Shen
Journal:  Doc Ophthalmol       Date:  2009-09-12       Impact factor: 2.379

2.  Intraocular pressure and visual field changes in normal-tension glaucoma patients treated using either unoprostone or latanoprost: a prospective comparative study.

Authors:  Daisuke Takemoto; Tomomi Higashide; Yoshiaki Saito; Shinji Ohkubo; Sachiko Udagawa; Hisashi Takeda; Kazuhisa Sugiyama
Journal:  Clin Ophthalmol       Date:  2017-09-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.